Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a previously FDA-approved medication that is known
to help with allergy symptoms to see if it can decrease symptoms in patients with Meniere's
Disease.